Comprehensive Ankylosing Spondylitis Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034

What market dynamics are playing a key role in accelerating the growth of the ankylosing spondylitis market?
The growth of the ankylosing spondylitis market is projected to be spurred by the expanding elderly population. This is reference to the demographic shift where the population structure changes and we are seeing a larger quantity and proportion of individuals aged 60 and above. Drugs for ankylosing spondylitis bolster mobility and alleviate pain for older individuals diagnosed with this condition. For instance, the United Nations Department of Economic and Social Affairs (UN DESA), a division of the UN Secretariat based in the US, projected in January 2023 that the worldwide population of those 65 and older will more than double, ballooning from 761 million in 2021 to 1.6 billion by 2050. Hence, the increasing elderly population is fueling the ankylosing spondylitis market's expansion.

Get Your Ankylosing Spondylitis Market Report Here:
https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report

How will the growth rate of the ankylosing spondylitis market shape industry trends by 2034?
The market size for ankylosing spondylitis has experienced robust growth in the past few years. Forecasts predict an escalation from $5.9 billion in 2024 to $6.36 billion in 2025, marking a compound annual growth rate (CAGR) of 7.8%. The previous growth can be credited to factors such as the discovery of hla-b27, the development of biologic treatments, pain management strategies, patient advocacy and awareness, NSAIDs, and disease-modifying drugs.

The market size for ankylosing spondylitis is projected to witness substantial expansion in the coming years. It is predicted to escalate to $8.71 billion by 2029, with a compound annual growth rate (CAGR) of 8.2%. The market surge in the forecast period is linked to factors such as the emphasis on personalized medicine, the innovation of novel biologics, early detection and intervention, adjustment of lifestyle and diet, the use of telemedicine, and remote surveillance. Key trends during the forecast period include increasing availability of biosimilars, targeted approaches to manage pain, insistence on patient-reported outcomes (pros), community-backed initiatives, and the exploration of regenerative medicine.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp

What trends are poised to drive the future success of the ankylosing spondylitis market?
Innovations in treatment possibilities have emerged as a crucial trend gaining traction in the ankylosing spondylitis market. To maintain their market position, businesses focusing on ankylosing spondylitis are developing novel therapeutic alternatives. An illustration of this trend was seen in April 2022, when US-biopharmaceutical firm AbbVie Inc. received approval from the U.S. Food and Drug Administration (FDA) for RINVOQ, a new oral treatment for adults suffering from active ankylosing spondylitis (AS). This medication provides a new therapy choice for patients who have not found relief with TNF blockers and has demonstrated significant progress in alleviating disease symptoms like back pain and impaired physical function. Owing to its swift effectiveness and safety profile demonstrated in clinical trials, it has emerged as a crucial breakthrough in the management of this chronic inflammatory condition, thereby diversifying the range of treatment options available to patients.

Which primary segments of the ankylosing spondylitis market are driving growth and industry transformations?
The ankylosing spondylitis market covered in this report is segmented -

1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Steroids, Physical Therapies, Surgery
2) By Molecule: Biologics, Biosimilar, Small Molecules
3) By Route Of Administration: Parenteral, Oral, Other Routes
4) By Application: Juveniles, Adults
5) By End User: Hospitals, Clinics, Research Laboratories, Other End Users

Subsegments:
1) By Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Over-The-Counter NSAIDs, Prescription NSAIDs
2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs, Targeted DMARDs
3) By Biological Therapies: TNF Inhibitors, IL-17 Inhibitors
4) By Steroids: Oral Steroids, Injectable Steroids
5) By Physical Therapies: Physiotherapy, Exercise Programs
6) By Surgery: Joint Replacement Surgery, Spinal Surgery

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11962

Which geographical regions are pioneering growth in the ankylosing spondylitis market?
North America was the largest region in the ankylosing spondylitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the ankylosing spondylitis market landscape?
Major companies operating in the ankylosing spondylitis market include Pfizer Inc., Johnson & Johnson Pvt. Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Amgen Inc., Cedars-Sinai, Viatris Inc., Astellas Pharma Inc., AstraZeneca plc, UCB Inc., Cipla Inc., Zydus Lifesciences Limited, Celltrion Inc., Hetero Labs Ltd., UCSF Health, Janssen Biotech Inc., Reliance Life Sciences Pvt. Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp

What Is Covered In The Ankylosing Spondylitis Global Market Report?

• Market Size Forecast: Examine the ankylosing spondylitis market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the ankylosing spondylitis market for a structured understanding.
• Key Players Overview: Analyze major players in the ankylosing spondylitis market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the ankylosing spondylitis market.
• Segment Contributions: Evaluate how different segments drive overall growth in the ankylosing spondylitis market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the ankylosing spondylitis market.
• Industry Challenges: Identify potential risks and obstacles affecting the ankylosing spondylitis market.
• Competitive Landscape: Review strategic developments in the ankylosing spondylitis market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.